1059115

BioReliance Corporation — FEI 1122041

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)